Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Treasury Shares (2021 - 2026)

Axsome Therapeutics' Treasury Shares history spans 6 years, with the latest figure at $64281.0 for Q1 2026.

  • On a quarterly basis, Treasury Shares changed 0.0% to $64281.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $64281.0, a 0.0% change, with the full-year FY2025 number at $1.0 million, up 11.67% from a year prior.
  • Treasury Shares hit $64281.0 in Q1 2026 for Axsome Therapeutics, down from $1.0 million in the prior quarter.
  • Over the last five years, Treasury Shares for AXSM hit a ceiling of $1.0 million in Q2 2025 and a floor of $64281.0 in Q1 2025.
  • Historically, Treasury Shares has averaged $693554.5 across 5 years, with a median of $787134.0 in 2023.
  • Biggest five-year swings in Treasury Shares: skyrocketed 126.7% in 2022 and later crashed 93.03% in 2025.
  • Tracing AXSM's Treasury Shares over 5 years: stood at $686375.0 in 2022, then rose by 17.16% to $804150.0 in 2023, then grew by 12.78% to $906944.0 in 2024, then increased by 11.67% to $1.0 million in 2025, then crashed by 93.65% to $64281.0 in 2026.
  • Business Quant data shows Treasury Shares for AXSM at $64281.0 in Q1 2026, $1.0 million in Q4 2025, and $64281.0 in Q3 2025.